Endometriosis
Conditions
Interventions
Control Group:Acupoint application of placebo patch with placebo treatment
Experimental group:Acupoint application, detumescence and pain relief combined with traditional Chinese medicine
Sponsors
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria of endometriosis; 2. Age 18-45, menstrual cycle 21-35 days, period 3-7 days; 3. Patients with mass diameter < 4 cm; 4.35IU/L < serum CA125 < 80IU/L; 5. Informed consent and signing of informed consent.
Exclusion criteria
Exclusion criteria: 1. Dysmenorrhea caused by various primary dysmenorrhea or other diseases; 2. Have accepted other new drug clinical experimenter in recent 3 months; 3. People with coagulation disorder; 4. People who have been allergic to multiple drugs or have an allergic constitution; 5. Persons with combined mental illness, alcoholism and/or psychoactive substance substance abuse and dependence; 6. Patients with skin trauma, ulcers, skin infection or scar at the application site and those who are allergic to the patch; 7. Pregnant or lactating women. Note: any one or more of the above items should be excluded and cannot be selected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uterine size, mass size;Dysmenorrhea symptom score;CA125;Dysmenorrhea pain score; | — |
Countries
China
Contacts
Public ContactSunzhengao
Outcome results
None listed